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Post-operative levamisole may compromise early healing of experimental
intestinal anastomoses
JWD de Waard*, T Wobbes, BM de Man, CJ van der Linden and T Hendriks
Department ofSurgery, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Summary There exists growing interest in immediate post-operative local adjuvant therapy after resection of
intestinal malignancies. It is therefore necessary to assess its potential effect on the healing of intestinal
anastomoses. Five groups (n = 20) of rats underwent resection and anastomosis of both ileum and colon: a
control group and four experimental groups receiving intraperitoneal 5-fluorouracil (5-FU), 5-FU plus
leucovorin, 5-FU plus levamisole or levamisole alone, on the day of surgery and the next 2 days. Animals were
killed 3 or 7 days after operation. Another three groups (n = 6) of animals were used to compare anastomotic
collagen synthetic capacity in control rats or rats receiving 5-FU or 5-FU plus levamisole. On the third
post-operative day, the average anastomotic bursting pressure in the 5-FU/levamisole group was reduced by
36% as compared with the control group, both in ileum (P = 0.02) and in colon (P = 0.01). Values in the
other groups were similar to those in the control group. Anastomotic breaking strength was significantly
(P<0.025) lowered in the ileum from the levamisole group at both days 3 and 7. Anastomotic collagen
synthetic capacity was strongly reduced in the 5-FU and 5-FU/levamisole groups. However, there was no
significant difference between the control group and the four experimental groups with regard to anastomotic
hydroxyproline concentration and content, either 3 or 7 days after operation. Thus, limited use of levamisole,
alone or in combination with intraperitoneal 5-FU, may compromise intestinal healing.
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The recurrence rate is high after surgical treatment of col-
orectal cancer. This has prompted extensive clinical investiga-
tions into the use of chemotherapy as an adjunct to surgery.
Until now, disappointing results have been obtained despite
enormous preclinical and clinical research efforts. Although a
meta-analysis of its use shows only limited benefit (Buyse et
al., 1988), 5-Fluorouracil (5-FU) remains the most effective
single agent, and current research aims to improve its efficacy
by combinations with other agents (Mayer, 1992; Kemeny et
al., 1993). A number of studies have confirmed an improved
therapeutic activity if 5-FU is combined with folinic acid
(leucovorin) (Mayer, 1992; Kemeny et al., 1993), while the
combination of 5-FU with levamisole also attracts con-
siderable attention (Moertel et al., 1990; Stevenson et al.,
1991). Major questions still to be resolved in the treatment of
patients by surgery and subsequent adjuvant chemotherapy
include, next to the choice of cytostatic agents, timing and
route of administration.
Recurrent disease is mainly found in the liver, at the
operative site and on the peritoneal surface. It has been
suggested that intraperitoneal chemotherapy would be better
than systemic chemotherapy since it lowers the likelihood of
systemic complications while being efficient at the sites of
both local and distant - hepatic - recurrences (Cunliffe and
Sugarbaker, 1989). Intraperitoneal 5-FU reportedly prevents
hepatic metastasis in experimental colon cancer (Nordlinger
et al., 1991). Since the efficiency of adjuvant therapy appears
to be reduced with increasing time interval between operation
and administration of cytostatic agents (Fisher et al., 1993),
there are excellent reasons to start treatment immediately
after operation (Harris and Mastrangelo, 1991) when the
tumour burden is small. As a consequence, there exists grow-
ing interest in immediate post-operative local adjuvant
therapy after resection of intestinal malignancies (Sugarbaker
et al., 1990; Sugarbaker, 1994). A number of studies using
immediate post-operative intraperitoneal 5-FU are in pro-
gress (Glimelius and Pahlman, 1992; Graf et al., 1994).
It thus becomes imperative to assess the potential effects of
such therapies on the healing of intestinal anastomoses.
Administration of cytostatic agents in the perioperative
period may be detrimental to anastomotic healing. Loss of
strength, particularly in the early phase when strength is
relatively low, may increase the chances of anastomotic
leakage, which is a potentially devastating surgical complica-
tion with concomitant high morbidity and mortality. Indeed,
earlier experiments in our laboratory have shown that
perioperative intraperitoneal combination chemotherapy con-
taining 5-FU, next to bleomycin and cisplatinum, greatly
reduces anastomotic strength (de Roy van Zuidewijn et al.,
1991). Intraperitoneal 5-FU affects anastomotic collagen syn-
thetic capacity far more severely than intravenous 5-FU
(Martens et al., 1992a). Daily intraperitoneal administration
of 5-FU alone from the day of surgery onwards until
sacrifice after 7 days strongly inhibits anastomotic repair in
the rat intestine (Graf et al., 1992; de Waard et al., 1995).
The present study was undertaken to assess if additional
medication with leucovorin or levamisole would add to this
negative effect. We reported recently that intraperitoneal
administration of 5-FU alone on the day of operation and
the next 2 days does not significantly reduce strength in
experimental intestinal anastomoses (de Waard et al., 1993).
Since we expected any additional effect of leucovorin and
levamisole to be more easily observed under conditions in
which 5-FU alone does not (yet) impair anastomotic healing,
we limited drug administration to the first 3 days.
Materials and methods
Animals
Altogether, 118 male outbred Wistar/Cpb:WU rats, weighing
between 200 and 300 g, were used. They were housed two
animals per cage and had free access to water and standard
laboratory chow (diet AM II, Hope Farms, Woerden, The
Netherlands).
For the measurement of anastomotic strength and hydrox-
yproline content, 100 animals were randomly divided into
five groups of 20 animals each; a control group, a 5-FU
group, a levamisole group and two groups receiving 5-FU
plus levamisole or leucovorin. Within each group, ten rats
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1995were killed 3 and 7 days after operation. Collagen synthesis
was measured in three groups of animals (n = 6): a control
group, a 5-FU group and a group which received 5-FU plus
levamisole. These rats were killed 3 days after operation.
The study was approved by the Animal Ethics Review
Committee of the Faculty of Medicine, University of
Nijmegen.
Drug administration
5-FU (Abic, Netanya, Israel) was given intraperitoneally in a
dose of 20 mg kg' body weight (concentration 1 mg ml'
saline). This is the same dose we used previously (de Waard
et al., 1993, 1995) and represents the highest dose which, in
combination with surgery, did not result in a significant
mortality. Levamisole (Janssen, Beerse, Belgium) was given
orally, by means of a stomach tube, in a dosage of 5 mg kg-'
body weight. Leucovorin (Cyanamid, Etten-Leur, The
Netherlands) was administered intravenously in a dosage of
10 mg kg'- body weight. All drugs were given once a day, on
the day of operation and the next 2 days. The animals in the
control groups received intraperitoneal saline daily.
Operativeprocedure
After an intraperitoneal injection of sodium pentobarbital, a
midline incision was made and 1 cm of both small and large
bowel was resected at 15 cm proximal to the ileocaecal junc-
tion and 3 cm proximal to the rectal peritoneal reflection
respectively. Continuity was restored microsurgically by the
construction of an inverted one-layer seromuscular end-to-
end anastomosis with eight interrupted sutures of 8 x 0
monofilament material (Ethicon, Sommerville, USA). The
abdomen was closed in two layers with a continuous 3 x 0
silk suture for the fascia and staples for the skin.
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lected tissue explants of 1-2 mm2, collected from control
segments removed at operation and from anastomotic tissue
removed 3 days after operation, were incubated in medium
containing [3H]proline for 3 h and the radioactivity incor-
porated into total protein was counted. Subsequently, in
order to determine proline incorporation into collagen, excess
purified collagenase was added. The radioactivity in the
supernatant represents CDP, as a measure of the amount of
collagen synthesised. Subtraction of the radioactivity in the
CDP fraction from that in total protein yields the incorpora-
tion into non-collagenous protein (NCP). The relative col-
lagen synthesis (RCS) was calculated with the formula (Peter-
kofsky et al., 1981) that takes into account the enrichment of
proline in collagen compared with other proteins:
Relative collagen - CDP x 100%
synthesis (%) (NCP x 5.4) + CDP
Incorporation is expressed on the basis of sample wet weight,
DNA (Burton, 1956) content or protein (Smith et al., 1985)
content.
Statistical analysis
Pairwise comparisons of groups were performed with a Wil-
coxon test using a level of significance of 2a/k, where k is the
total number of pairwise comparisons.
This way, comparison of the four experimental groups
with the control group (Figures 1-3) yields a significant
difference if P<0.025. Comparison of the two experimental
groups which were used to analyse collagen synthesis with
the control group (Figure 1 and Tables I and II) yields a
significant difference at P<0.05.
Results
Analyticalprocedures
The rats were killed by an intraperitoneal overdose of sodium
pentobarbital. After opening the abdominal wound and iden-
tifying the anastomoses, the adhesions were cut as far as
possible without injuring the intestine. An intestinal segment
with the anastomosis in the middle was removed, with the
sutures left in place. This segment was attached to an
infusion pump filled with methylene blue-stained saline. The
pressure was raised with an infusion rate of 4mlmin-' and
recorded graphically. Both the bursting pressure, i.e. the
maximum pressure recorded immediately before sudden loss
of pressure, and the site of rupture were noted. Thereafter,
the segment was placed in a tensiometer and the breaking
strength was recorded. Thus, both the bursting pressure and
breaking strength were measured in the same anastomotic
segment. The validity of this procedure had been confirmed
in a pilot experiment. Two groups of 20 animals were
operated and killed after 3 or 7 days (n = 10 each). In the
first group, only the anastomotic breaking strength was
measured: in the ileum, average values were 23 ± 7 (s.d.) g at
day 3 and 128 ± 35 g at day 7. In the second group, measure-
ment of the bursting pressure preceded analysis of the break-
ing strength. Still, the breaking strength in this group reached
similar levels, 19 ± 12 g and 127 ± 33 g respectively. Like-
wise, similar values for the colonic breaking strength were
found in both groups.
The anastomotic segment was then cleaned from the sur-
rounding tissue and a 5 mm segment with the suture line in
the middle was collected. The samples were frozen immed-
iately and stored in liquid nitrogen until processing. After
weighing, the samples were pulverised and lyophilised and
the hydroxyproline content was measured as described
previously (Hesp et al., 1984).
Collagen synthesis was analysed as the ex vivo collagen
synthetic capacity in intestinal explants by measuring the
incorporation of proline into collagenase-digestible protein
(CDP), according to a procedure validated before for rat
intestinal tissue (Martens et al., 1992b). Briefly, freshly col-
No animals died prematurely. All rats lost weight after oper-
ation. In the control group the average maximal weight loss
was 9% on the first post-operative day. Thereafter, animals
regained weight. At day 7, the average body weight was
106% of weight before operation. Rats in all four experi-
mental groups exhibited qualitatively and quantitatively
similar changes in body weight.
The average anastomotic bursting pressure - a measure of
resistance to increasing intraluminal pressure - at day 3 is
depicted in Figure 1. At this time point, the bursting site was
always within the suture line. 5-FU, administered either alone
or in combination with leucovorin, did not significantly lower
the bursting pressure. However, if levamisole and 5-FU were
given simultaneously, the anastomotic bursting pressure was
significantly reduced by 36%, both in the ileum (P = 0.02)
and in the colon (P = 0.01). Levamisole alone had no effect.
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Figure 1 Anastomotic bursting pressure after 3 days. Bars repre-
sent average values (n = 10, except for control group, where
n = 8) + s.d. 1, Control group; 2, 5-FU group; 3, 5-FU/
leucovorin group; 4, 5-FU/levamisole group; 5, levamisole group.
*Significantly (P<0.025, see Materials and methods) different
from control group.
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Figure 2 Anastomotic breaking strength. Bars represent average
values (n = 10) + s.d. 1, Control group; 2, 5-FU group; 3, 5-FU/
leucovorin group; 4, 5-FU/levamisole group; 5, levamisole group.
*Significantly (P<0.025, see Materials and methods) and
+ almost-significantly (P<0.05) different from control group.
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Figure 3 Anastomotic hydroxyproline content. Bars represent
average values (n = 10) + s.d. 1, Control group; 2, 5-FU group; 3,
5-FU/leucovorin group; 4, 5-FU/levamisole group; 5, levamisole
group.
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Table I Ex vivo synthesis of collagen and non-collagen protein in ileal anastomoses
Control group 5-FU group 5-FU/LEV group
Collagen
d.p.m./total 36 926 ± 7784 15 053 ± 4092* 17 325 ± 5225*
d.p.m.Lg-' DNA 194± 30 115±30* 126±33*
d.p.m. mg-' wet weight 595 ± 72 297 ± 47* 310 ± 41*
d.p.m. mg-' protein 14 786 ± 1953 6819 ± 1292* 8573 ± 1912*
RCS (%) 1.02 ± 0.18 0.73 ± 0.10* 0.60 ± 0.06*
Non-collagen
d.p.m./total 626 155 ± 81 428 384 147 ± 96 986* 522 343 ± 17 2077
d.p.m.fig-' DNA 3015 ± 770 2912 ± 716 3747 1045
d.p.m. mg-' wet weight 9697 ± 1572 7556 ± 1215 9439 ± 1355
d.p.m. mg-' protein 246 721 ± 81 428 180 250 ± 27049 255 754 48956
Explants from anastomotic tissue were collected 3 days after operation and incubated for 3 h with
4.5 lCiof[3H]proline.Collagensynthesisisexpressed asradioactivityincollagenase-digestible proteinand
as percentage relative collagen synthesis (RCS). Non-collagen protein synthesis is expressed as
radioactivity in non-collagenous protein. Data represent average values ( + s.d) from six animals.
*Significant (P<0.05) difference with the control group.
Table II Ex vivo synthesis of collagen and non-collagen protein in colonic anastomoses
Control group S-FU group 5-FU/LEVgroup
Collagen
d.p.m./total
d.p.m./Lg-' DNA
d.p.m. mg-' wet weight
d.p.m. mg-' protein
RCS (%)
57 467 ± 20 399
221 ± 62
773± 150
17 454 ± 3214
1.72 ± 0.32
31 723± 11491*
132 ± 26*
429 ± 80*
9490± 1997*
1.29 ± 0.19*
Non-collagen
d.p.m./total 670 878 ± 62 818 438 772 ± 120 923* 488 899 ± 64 817*
d.p.m. lg-I DNA 2423 ± 794 1902 ± 239 1836 ± 383
d.p.m. mg-' wet weight 9168 ± 1597 6175 ± 723* 6267 ± 673*
d.p.m. mg- 'protein 198 068 ± 41 505 135 985 ± 16 191* 127 056 ± 34 833*
Explants from anastomotic tissue were collected 3 days after operation and incubated for 3 h with
4.5fjCi of[3H]proline. Collagen synthesis isexpressed asradioactivity incollagenase-digestible proteinand
as percentage relative collagen synthesis (RCS). Non-collagen protein synthesis is expressed as
radioactivity in non-collagenous protein. Data represent average values ( + s.d.) from six animals.
*Significant (P<0.05) difference with the control group.
27 269 ± 7375*
101 ± 22*
337 ± 58*
6948 ± 2611*
1.04 ± 0. 17*
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Figure 4 Collagen synthetic capacity in control and anastomotic
segments. Bars represent average values (n = 6) + s.d. Ex vivo
collagen synthesis in control segments removed at operation
(closed bars) and in anastomotic tissue collected 3 days after
operation (open bars). *Significantly (P<0.05) different from
control group.
At 7 days after operation the bursting site was always outside
the suture line. Therefore, the bursting pressures measured at
this time (data not shown) did not represent actual anas-
tomotic strength.
The average anastomotic breaking strength, a measure of
the ability to withstand longitudinal forces, is shown in
Figure 2. The breaking site was invariably within the wound
area both 3 and 7 days after operation. At day 3, similar
values were found in the control, 5-FU and 5-FU/leucovorin
groups. The average breaking strength in both the 5-FU/
levamisole and the levamisole group was lower than in the
control group. However, this effect was only significant
(P = 0.016) in ileal anastomoses in the levamisole group. At
day 7, ileal anastomoses in the 5-FU/leucovorin (P = 0.018)
and levamisole (P = 0.025) groups were significantly weaker
than those in the control group. This was almost (P = 0.038)
the case for colonic anastomoses in the 5-FU/levamisole
group.
Hydroxyproline, as a measure of collagen, was quantitated
in 5 mm segments containing the anastomosis (Figure 3). No
differences between the control group and the various experi-
mental groups were observed. In the control group the hyd-
roxyproline content increased from day 3 to day 7 by a
factor of 2.7 in ileal anastomoses and by a factor of 1.6 in
colonic anastomoses. This increase was similar in the animals
receiving the various cytostatic drugs. Likewise, no differ-
ences were found for the hydroxyproline concentrations in
the anastomotic segments. Average hydroxyproline concent-
rations were 7.0 ± 1.3 and 9.6 ± 1.8 jig mg-' dry weight in 3-
and 7-day-old ileal anastomoses respectively; corresponding
values in colonic anastomoses were 9.7 ± 0.7 and 13.8 ±
1.9 pg mg-' dry weight. Similar values were measured in the
experimental groups (data not shown).
We also compared the collagen synthetic capacity, meas-
ured ex vivo in tissue explants, in the control, 5-FU and
5-FU/levamisole groups 3 days after operation. In the cont-
rol group, this was strongly increased in anastomotic tissue in
comparison with control segments removed at operation
(Figure 4), 5-fold in ileum and nearly 3-fold in colon. In both
experimental groups anastomotic collagen synthetic capacity,
calculated on the basis of DNA content, was significantly
reduced. This effect was also evident ifcollagen synthesis was
expressed per anastomosis (d.p.m./total) or on the basis of
wet weight or protein (Tables I and II). Synthesis of non-
collagenous proteins was affected less strongly, particularly in
the ileum. We found no differences between the 5-FU and
the 5-FU/levamisole groups.
Discussion
If resection of an intestinal tumour is followed immediately
by adjuvant chemotherapy, this procedure constitutes a
potential hazard for the healing anastomosis. The present
results confirm that 5-FU alone, administered on the day of
surgery and the next 2 days, does not significantly suppress
the development of anastomotic strength in the first post-
operative week. However, levamisole indeed appears to exert
a negative effect in this respect. The strength of the intact
and anastomosed intestinal wall is largely derived from col-
lagen, the major structural protein in the submucosal layer.
During the first post-operative days wound strength is
thought to solely depend on the suture-holding capacity of
existing collagen fibrils (Hogstrom et al., 1985). From app-
roximately 3 days after operation, the anastomosis starts to
gain strength. Restoration of strength to the level of the
uninjured intestine depends on de novo synthesis of collagen.
In the control animals, the anastomotic collagen synthetic
capacity is already strongly stimulated after 3 days and the
anastomotic collagen (hydroxyproline) content increases con-
siderably between 3 and 7 days after operation; a similar rise
in breaking strength is observed over the same period.
Administration of 5-FU until day 3 significantly reduces the
collagen synthetic capacity in the anastomotic area without
affecting anastomotic strength measured 3 or 7 days after
operation. This indicates that the enhanced collagen synthetic
capacity, which may be observed as early as 3 h after oper-
ation (Martens and Hendriks, 1991) is not necessary - at
least not entirely - for retaining wound strength during the
first post-operative days. The fact that the increase between 3
and 7 days in both anastomotic strength and collagen con-
tent is unimpeded in the 5-FU group means that the collagen
synthetic capacity is normalised very quickly after cessation
of drug administration. Alternatively, it could be argued that
the collagen synthetic capacity normally observed in the
wound area in fact constitutes an overcapacity: it is not fully
used for collagen deposition and a moderate inhibition does
not necessarily lead to diminished accumulation of wound
collagen. Thus, immediate post-operative chemotherapy with
5-FU alone, administered for 3 days, appears to be relatively
harmless for anastomotic integrity. However, if the drug is
given over a longer period anastomotic strength is impaired
(Graf et al., 1992; de Waard et al., 1995).
It seems well established that the therapeutic activity of
5-FU can be improved by biochemical modulation with
leucovorin (folinic acid) (Mayer, 1992; Kemeny et al., 1993).
Graf et al. (1992) recently reported on the effect of simul-
taneous administration of 5-FU and leucovorin on anas-
tomotic healing in the rat colon. In this experiment, the
drugs were given daily until sacrifice at day 7. This way,
5-FU alone reduced anastomotic strength and addition of
leucovorin does not lead to further deterioration. The present
experiment where 5-FU administration is limited to the first 3
days and does not by itself reduce anastomotic strength, does
not fully support these results. Although neither the bursting
pressure nor the breaking strength of the anastomoses is
affected by day 3, the ileal breaking strength is reduced
significantly in the 5-FU/leucovorin group 7 days after oper-
ation. This finding precludes the unequivocal conclusion that
addition of leucovorin to a post-operative regimen of 5-FU
constitutes no additional hazard for anastomotic healing in
the intestine and warrants further investigation.
Post-operative chemotherapy with 5-FU and levamisole
may also be beneficial to a certain class of patients with
colorectal carcinoma (Moertel et al., 1990; Stevenson et al.,
u
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1991). Levamisole, in conjunction with intravenous 5-FU,
has already been given in a small study on the first 3 post-
operative days following curative surgery for colorectal
cancer (Windle et al., 1987). Our results indicate that
levamisole, administered immediately after operation alone
or in combination with intraperitoneal 5-FU, may be harm-
ful to the development ofanastomotic strength. In particular,
the bursting pressure of 3-day-old anastomoses is reduced in
the 5-FU/levamisole group but not in the 5-FU group. Also,
the average anastomotic breaking strength in the levamisole
group is reduced after both 3 and 7 days, though significantly
so only in the ileum.
Comparison of the collagen synthetic capacity in 3-day-old
anastomoses yields no difference between the 5-FU and 5-
FU/levamisole groups. We have already indicated above that
at this time point anastomotic strength is probably indepen-
dent of de novo collagen synthesis and largely depends on
sold' collagen. Degradation of existing collagen fibrils, which
provide strength to the matrix anchoring the sutures, may
result in loss of wound strength. Although the anastomotic
collagen content is similar in all groups, the methodology
used would be unable to detect very localised loss ofcollagen
restricted to, for instance, the immediate area around the
sutures (Hendriks and Mastboom, 1990). It may be that
levamisole somehow stimulates collagenolysis. Levamisole
has been reported to exert a broad range of immun-
omodulatory effects (Stevenson et al., 1991). It increases the
chemotactic response of granulocytes, which cells accumulate
immediately after wounding in the anastomotic area and are
an important source for collagenolytic enzymes (Hasty et al.,
1990). Also, levamisole up-regulates interleukin 1 (IL-1) pro-
duction by macrophages (Kimball et al., 1992), and IL-1 is
known to strongly enhance collagenase production by fibro-
blasts and other cells (Circolo et al., 1991).
Thus, our data suggest that limited use of 5-FU, in com-
bination with leucovorin, may not be entirely harmless to
anastomotic repair. Administration of levamisole, alone or in
combination with 5-FU, in the perioperative period may
negatively affect intestinal healing. The mechanism(s) respon-
sible for this effect remain to be elucidated.
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